Updated:
ZAKA
ZAKA is a seed and pre-seed VC fund investing mainly in the US and Europe, with a focus on Health & Biotech and Industrial Tech. The firm seeks entrepreneurs...
ZAKA
ZAKA is a seed and pre-seed VC fund investing mainly in the US and Europe, with a focus on Health & Biotech and Industrial Tech. The firm seeks entrepreneurs with global ambition and supports them by creating a bridge between North America and Europe. It reports 95 companies invested, 4 exits, and 1 unicorn.
General information
Firm type
Venture Capital
Year founded
2020
Location
Region
Europe
Country
Czech Republic
City
Prague
Corporate office
Prague, Czech Republic
Principals
Andrej Petrus
Investment Committee Lead
Jan Kasper
Co-Founder & Managing Partner
Peter Zalesak
General Partner
Filip Orth
Head of Investor Relations
Natalia Sachova
Deal Flow & Portfolio Management Lead
Richard Kopunik
Operating Partner
Jan Buza
Deal Assessment
Samo Zalesak
Analyst
Jozef Macak
Analyst
Sector focus
Frequently asked questions
Who runs investment decisions at ZAKA?
Andrej Petrus leads the investment committee. A Forbes 30 Under 30 listee and Newton Venture Fellow, he joined ZAKA after experience in venture building and M&A and strategy consulting. He is based in Prague and is the principal decider on capital deployment.
How does ZAKA source proprietary deal flow?
ZAKA maintains an active Silicon Valley presence through Filip Orth, a Santa Clara University graduate based in the Bay Area, and conducts periodic multi-week team trips for founder meetings across San Francisco, Palo Alto, and Stanford. The firm's general partners also draw on their operating networks from sectors including retail, ecommerce, energy, and real estate.
What investment stages does ZAKA typically target?
The firm targets seed and pre-seed rounds in the US and Europe. Its deal flow spans early-stage through growth, with most disclosed activity concentrated at the earliest institutional entry points, often alongside or after accelerator programs and angel syndicates.
Which sectors does ZAKA concentrate on?
ZAKA explicitly highlights Health & BioTech and Industrial Tech as priority verticals, citing one of the best Healthcare & Life Sciences portfolios in continental Europe on its website. Beyond those, the portfolio reaches into space, quantum computing, AI, enterprise SaaS, hospitality, fintech, and mobility.
Where does the underlying capital come from?
The wealth source is not publicly disclosed. ZAKA's founding general partners, Jan Kasper and Peter Zalesak, built their own operating businesses in retail, ecommerce, energy, real estate, and agriculture across Central Europe. Whether the fund pools wholly proprietary capital or accepts external qualified investors at a minimum $130,000 ticket has not been definitively stated.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: